The Serum Institute of India (SII) will buy the vaccine components
from Novavax and the two companies will equally split the revenue from
the sale of the product, net of agreed costs, Novavax said in a US
regulatory filing on Wednesday.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/serum-institute-inks-deal-to-produce-us-based-biotech-firm-novavaxs-covid-vaccine/articleshow/77401690.cms
No comments:
Post a Comment